L1TD1 - a prognostic marker for colon cancer

Deepankar Chakroborty,Maheswara Reddy Emani,Riku Klén,Camilla Böckelman,Jaana Hagström,Caj Haglund,Ari Ristimäki,Riitta Lahesmaa,Laura L. Elo
DOI: https://doi.org/10.1186/s12885-019-5952-2
IF: 4.638
2019-07-23
BMC Cancer
Abstract:<h3 class="Heading">Background</h3><p class="Para">Prognostic markers specific to a particular cancer type can assist in the evaluation of survival probability of patients and help clinicians to assess the available treatment modalities.</p><h3 class="Heading">Methods</h3><p class="Para">Gene expression data was analyzed from three independent colon cancer microarray gene expression data sets (<em class="EmphasisTypeItalic">N</em> = 1052). Survival analysis was performed for the three data sets, stratified by the expression level of the LINE-1 type transposase domain containing 1 (<em class="EmphasisTypeItalic">L1TD1</em>). Correlation analysis was performed to investigate the role of the interactome of L1TD1 in colon cancer patients.</p><h3 class="Heading">Results</h3><p class="Para">We found <em class="EmphasisTypeItalic">L1TD1</em> as a novel positive prognostic marker for colon cancer. Increased expression of <em class="EmphasisTypeItalic">L1TD1</em> associated with longer disease-free survival in all the three data sets. Our results were in contrast to a previous study on medulloblastoma, where high expression of <em class="EmphasisTypeItalic">L1TD1</em> was linked with poor prognosis. Notably, in medulloblastoma <em class="EmphasisTypeItalic">L1TD1</em> was co-expressed with its interaction partners, whereas our analysis revealed lack of co-expression of <em class="EmphasisTypeItalic">L1TD1</em> with its interaction partners in colon cancer.</p><h3 class="Heading">Conclusions</h3><p class="Para">Our results identify increased expression of <em class="EmphasisTypeItalic">L1TD1</em> as a prognostic marker predicting longer disease-free survival in colon cancer patients.</p>
oncology
What problem does this paper attempt to address?